Cargando…
Molecular Imaging of Aortic Valve Stenosis with Positron Emission Tomography
Aortic valve stenosis (AVS) is an increasingly prevalent disease in our aging population. Although multiple risk factors for AVS have been elucidated, medical therapies capable of slowing down disease progression remain unavailable. Molecular imaging technologies are opening up avenues for the non-i...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319069/ https://www.ncbi.nlm.nih.gov/pubmed/35890111 http://dx.doi.org/10.3390/ph15070812 |
_version_ | 1784755459153985536 |
---|---|
author | Oostveen, Reindert F. Kaiser, Yannick Stroes, Erik S.G. Verberne, Hein J. |
author_facet | Oostveen, Reindert F. Kaiser, Yannick Stroes, Erik S.G. Verberne, Hein J. |
author_sort | Oostveen, Reindert F. |
collection | PubMed |
description | Aortic valve stenosis (AVS) is an increasingly prevalent disease in our aging population. Although multiple risk factors for AVS have been elucidated, medical therapies capable of slowing down disease progression remain unavailable. Molecular imaging technologies are opening up avenues for the non-invasive assessment of disease progression, allowing the assessment of (early) medical interventions. This review will focus on the role of positron emission tomography of the aortic valve with (18)F-fluorodeoxyglucose and (18)F-sodium fluoride but will also shed light on novel tracers which have potential in AVS, ranging from the healthy aortic valve to end-stage valvular disease. |
format | Online Article Text |
id | pubmed-9319069 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-93190692022-07-27 Molecular Imaging of Aortic Valve Stenosis with Positron Emission Tomography Oostveen, Reindert F. Kaiser, Yannick Stroes, Erik S.G. Verberne, Hein J. Pharmaceuticals (Basel) Review Aortic valve stenosis (AVS) is an increasingly prevalent disease in our aging population. Although multiple risk factors for AVS have been elucidated, medical therapies capable of slowing down disease progression remain unavailable. Molecular imaging technologies are opening up avenues for the non-invasive assessment of disease progression, allowing the assessment of (early) medical interventions. This review will focus on the role of positron emission tomography of the aortic valve with (18)F-fluorodeoxyglucose and (18)F-sodium fluoride but will also shed light on novel tracers which have potential in AVS, ranging from the healthy aortic valve to end-stage valvular disease. MDPI 2022-06-30 /pmc/articles/PMC9319069/ /pubmed/35890111 http://dx.doi.org/10.3390/ph15070812 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Oostveen, Reindert F. Kaiser, Yannick Stroes, Erik S.G. Verberne, Hein J. Molecular Imaging of Aortic Valve Stenosis with Positron Emission Tomography |
title | Molecular Imaging of Aortic Valve Stenosis with Positron Emission Tomography |
title_full | Molecular Imaging of Aortic Valve Stenosis with Positron Emission Tomography |
title_fullStr | Molecular Imaging of Aortic Valve Stenosis with Positron Emission Tomography |
title_full_unstemmed | Molecular Imaging of Aortic Valve Stenosis with Positron Emission Tomography |
title_short | Molecular Imaging of Aortic Valve Stenosis with Positron Emission Tomography |
title_sort | molecular imaging of aortic valve stenosis with positron emission tomography |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319069/ https://www.ncbi.nlm.nih.gov/pubmed/35890111 http://dx.doi.org/10.3390/ph15070812 |
work_keys_str_mv | AT oostveenreindertf molecularimagingofaorticvalvestenosiswithpositronemissiontomography AT kaiseryannick molecularimagingofaorticvalvestenosiswithpositronemissiontomography AT stroeseriksg molecularimagingofaorticvalvestenosiswithpositronemissiontomography AT verberneheinj molecularimagingofaorticvalvestenosiswithpositronemissiontomography |